Yuhang Chen1,2, Tao Zhou1, Dianjianyi Sun1, Xiang Li1, Hao Ma1, Zhaoxia Liang1,3, Yoriko Heianza1, Xiaofang Pei2, George A Bray4, Frank M Sacks5, Lu Qi6,7,8. 1. Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 1724, New Orleans, LA, USA. 2. Department of Public Health Laboratory Sciences, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China. 3. Obstetrical Department, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. 4. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA. 5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 6. Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 1724, New Orleans, LA, USA. lqi1@tulane.edu. 7. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. lqi1@tulane.edu. 8. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. lqi1@tulane.edu.
Abstract
PURPOSE: Obesity is a heterogeneous condition and distinct adiposity subtypes may differentially affect type 2 diabetes risk. We assessed relations between genetically determined subtypes of adiposity and changes in glycemic traits in a dietary intervention trial. METHODS: The four genetic subtypes of adiposity including waist-hip ratio-increase only (WHRonly+), body mass index-increase only (BMIonly+), WHR-increase and BMI-increase (BMI+WHR+), and WHR-decrease and BMI-increase (BMI+WHR-) were assessed by polygenetic scores (PGSs), calculated based on 159 single nucleotide polymorphisms related to BMI and/or WHR. We examined the associations between the four PGSs and changes in fasting glucose, insulin, β-cell function (HOMA-B) and insulin resistance (HOMA-IR) in 692 overweight participants (84% white Americans) who were randomly assigned to one of four weight-loss diets in a 2-year intervention trial. RESULTS: Higher BMI+WHR-PGS was associated with a greater decrease in 2-year changes in waist circumference in white participants (P = 0.002). We also found significant interactions between WHRonly+PGS and dietary protein in 2-year changes in fasting glucose and HOMA-B (P = 0.0007 and < 0.0001, respectively). When consuming an average-protein diet, participants with higher WHRonly+PGS showed less increased fasting glucose (β = - 0.46, P = 0.006) and less reduction in HOMA-B (β = 0.02, P = 0.005) compared with lower WHRonly+PGS. Conversely, eating high-protein diet was associated with less decreased HOMA-B among individuals with lower than higher WHRonly+PGS (β = - 0.02, P = 0.006). CONCLUSIONS: Distinct genetically determined adiposity subtypes may differentially modify the effects of weight-loss diets on improving glucose metabolism in white Americans. This trial was registered at clinicaltrials.gov as NCT00072995.
PURPOSE: Obesity is a heterogeneous condition and distinct adiposity subtypes may differentially affect type 2 diabetes risk. We assessed relations between genetically determined subtypes of adiposity and changes in glycemic traits in a dietary intervention trial. METHODS: The four genetic subtypes of adiposity including waist-hip ratio-increase only (WHRonly+), body mass index-increase only (BMIonly+), WHR-increase and BMI-increase (BMI+WHR+), and WHR-decrease and BMI-increase (BMI+WHR-) were assessed by polygenetic scores (PGSs), calculated based on 159 single nucleotide polymorphisms related to BMI and/or WHR. We examined the associations between the four PGSs and changes in fasting glucose, insulin, β-cell function (HOMA-B) and insulin resistance (HOMA-IR) in 692 overweight participants (84% white Americans) who were randomly assigned to one of four weight-loss diets in a 2-year intervention trial. RESULTS: Higher BMI+WHR-PGS was associated with a greater decrease in 2-year changes in waist circumference in white participants (P = 0.002). We also found significant interactions between WHRonly+PGS and dietary protein in 2-year changes in fasting glucose and HOMA-B (P = 0.0007 and < 0.0001, respectively). When consuming an average-protein diet, participants with higher WHRonly+PGS showed less increased fasting glucose (β = - 0.46, P = 0.006) and less reduction in HOMA-B (β = 0.02, P = 0.005) compared with lower WHRonly+PGS. Conversely, eating high-protein diet was associated with less decreased HOMA-B among individuals with lower than higher WHRonly+PGS (β = - 0.02, P = 0.006). CONCLUSIONS: Distinct genetically determined adiposity subtypes may differentially modify the effects of weight-loss diets on improving glucose metabolism in white Americans. This trial was registered at clinicaltrials.gov as NCT00072995.
Entities:
Keywords:
Adiposity subtypes; Body mass index; Gene–diet interaction; Glycemic traits; Polygenetic score; Waist–hip ratio
Authors: Francesca Santilli; Paola G Simeone; Maria T Guagnano; Marika Leo; Marica T Maccarone; Augusto Di Castelnuovo; Cristina Sborgia; Riccardo C Bonadonna; Ermanno Angelucci; Virginia Federico; Stefano Cianfarani; Lamberto Manzoli; Giovanni Davì; Armando Tartaro; Agostino Consoli Journal: Diabetes Care Date: 2017-09-14 Impact factor: 19.112
Authors: T Pischon; H Boeing; K Hoffmann; M Bergmann; M B Schulze; K Overvad; Y T van der Schouw; E Spencer; K G M Moons; A Tjønneland; J Halkjaer; M K Jensen; J Stegger; F Clavel-Chapelon; M-C Boutron-Ruault; V Chajes; J Linseisen; R Kaaks; A Trichopoulou; D Trichopoulos; C Bamia; S Sieri; D Palli; R Tumino; P Vineis; S Panico; P H M Peeters; A M May; H B Bueno-de-Mesquita; F J B van Duijnhoven; G Hallmans; L Weinehall; J Manjer; B Hedblad; E Lund; A Agudo; L Arriola; A Barricarte; C Navarro; C Martinez; J R Quirós; T Key; S Bingham; K T Khaw; P Boffetta; M Jenab; P Ferrari; E Riboli Journal: N Engl J Med Date: 2008-11-13 Impact factor: 91.245
Authors: Hanieh Yaghootkar; Luca A Lotta; Jessica Tyrrell; Roelof A J Smit; Sam E Jones; Louise Donnelly; Robin Beaumont; Archie Campbell; Marcus A Tuke; Caroline Hayward; Katherine S Ruth; Sandosh Padmanabhan; J Wouter Jukema; Colin C Palmer; Andrew Hattersley; Rachel M Freathy; Claudia Langenberg; Nicholas J Wareham; Andrew R Wood; Anna Murray; Michael N Weedon; Naveed Sattar; Ewan Pearson; Robert A Scott; Timothy M Frayling Journal: Diabetes Date: 2016-04-26 Impact factor: 9.461
Authors: Y-C Hwang; T Hayashi; W Y Fujimoto; S E Kahn; D L Leonetti; M J McNeely; E J Boyko Journal: Int J Obes (Lond) Date: 2015-04-29 Impact factor: 5.095
Authors: Cheryl L Rock; Shirley W Flatt; Bilge Pakiz; Kenneth S Taylor; Angela F Leone; Kerrin Brelje; Dennis D Heath; Elizabeth L Quintana; Nancy E Sherwood Journal: Diabetes Care Date: 2014-04-23 Impact factor: 19.112